Aptevo Therapeutics Inc (APVO)
2.40 x 1 2.49 x 4
Post-market by (Cboe BZX)
2.41 +0.03 (+1.26%) 03/14/25 [NASDAQ]
2.40 x 1 2.49 x 4
Post-market 2.47 +0.06 (+2.49%) 16:44 ET
for Fri, Mar 14th, 2025
Results
download Want to compare other data? Select Fields| Symbol | APVO | AZN | AMGN | GILD | VRTX |
| Company | Aptevo Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.41 | 76.87 | 312.23 | 112.89 | 507.00 |
| High | 2.48 | 77.68 | 314.51 | 113.36 | 519.68 |
| Low | 2.41 | 76.74 | 310.30 | 110.90 | 502.26 |
| Last | 2.41 | 77.60 | 313.71 | 111.44 | 504.77 |
| Change | +0.03 | +1.09 | +1.07 | -1.91 | +1.85 |
| % Change | +1.26% | +1.42% | +0.34% | -1.69% | +0.37% |
| Volume | 6,600 | 5,974,000 | 2,396,800 | 8,647,801 | 1,386,900 |
| 20-Day Average Volume | 46,195 | 6,421,485 | 3,094,225 | 9,477,630 | 1,373,060 |
| Previous Close | 2.38 | 76.51 | 312.64 | 113.35 | 502.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.03 | 75.73 | 309.61 | 112.32 | 483.97 |
| 20-Day Raw Stochastic | 3.40% | 84.61% | 52.71% | 46.87% | 77.97% |
| 20-Day Relative Strength | 32.83% | 63.22% | 58.71% | 59.92% | 64.04% |
| Weighted Alpha | -84.05 | +15.56 | +14.61 | +62.15 | +23.70 |
| Today's Opinion | 100% Sell | 56% Buy | 40% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 100% Sell | 56% Buy | 40% Buy | 100% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 8% Sell | 24% Sell | 100% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.12% since 03/07/25 | +0.13% since 03/07/25 | -3.43% since 03/07/25 | -5.08% since 03/07/25 | +3.38% since 03/07/25 |
| Low | 2.35 on 03/13/25 | 74.18 on 03/11/25 | 308.64 on 03/12/25 | 110.90 on 03/14/25 | 480.28 on 03/11/25 |
| High | 2.64 on 03/10/25 | 77.68 on 03/14/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 1-Month | |||||
| %Chg | -27.84% since 02/14/25 | +5.46% since 02/14/25 | +7.74% since 02/14/25 | +7.07% since 02/14/25 | +9.97% since 02/14/25 |
| Low | 2.35 on 03/13/25 | 73.54 on 02/21/25 | 289.00 on 02/18/25 | 104.00 on 02/18/25 | 451.99 on 02/18/25 |
| High | 4.00 on 02/28/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 3-Month | |||||
| %Chg | -41.08% since 12/13/24 | +16.55% since 12/13/24 | +15.92% since 12/13/24 | +21.32% since 12/13/24 | +8.85% since 12/13/24 |
| Low | 2.35 on 03/13/25 | 63.75 on 12/20/24 | 253.30 on 12/19/24 | 88.57 on 01/10/25 | 377.85 on 12/19/24 |
| High | 5.49 on 01/07/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -81.65% since 09/13/24 | -0.86% since 09/13/24 | -5.64% since 09/13/24 | +34.57% since 09/13/24 | +4.00% since 09/13/24 |
| Low | 2.35 on 03/13/25 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 19.06 on 10/22/24 | 79.76 on 10/02/24 | 339.17 on 09/23/24 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,515 | 240,650,176 | 168,526,576 | 138,781,360 | 129,619,888 |
| Shares Outstanding, K | 1,458 | 3,101,162 | 537,205 | 1,245,346 | 256,790 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -24,130,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -6,310,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 5.24 | 0.41 | 0.53 | 0.21 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -17.39 on 11/07/24 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 03/04/25 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.62 | 15.77 | 24.59 | 0.00 |